Nuvation Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Nuvation Bio and other ETFs, options, and stocks.About NUVB
Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer.
CEODavid T. Hung
CEODavid T. Hung
Employees220
Employees220
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2018
Founded2018
Employees220
Employees220
NUVB Key Statistics
Market cap2.16B
Market cap2.16B
Price-Earnings ratio-10.23
Price-Earnings ratio-10.23
Dividend yield—
Dividend yield—
Average volume6.40M
Average volume6.40M
High today$7.00
High today$7.00
Low today$6.27
Low today$6.27
Open price$6.57
Open price$6.57
Volume2.70M
Volume2.70M
52 Week high$9.75
52 Week high$9.75
52 Week low$1.54
52 Week low$1.54
Stock Snapshot
With a market cap of 2.16B, Nuvation Bio(NUVB) trades at $6.29. The stock has a price-to-earnings ratio of -10.23.
During the trading session on 2026-01-14, Nuvation Bio(NUVB) shares reached a daily high of $7.00 and a low of $6.27. At a current price of $6.29, the stock is +0.4% higher than the low and still -10.1% under the high.
Trading volume for Nuvation Bio(NUVB) stock has reached 2.7M, versus its average volume of 6.4M.
The stock's 52-week range extends from a low of $1.54 to a high of $9.75.
The stock's 52-week range extends from a low of $1.54 to a high of $9.75.
Analyst ratings
82%
of 11 ratingsBuy
81.8%
Hold
18.2%
Sell
0%
People also own
Based on the portfolios of people who own NUVB. This list is generated using Robinhood data, and it’s not a recommendation.